Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer

Clinical Trial ID NCT01266460

Rank	Title	Journal	Year	PubWeight™‹?›
1	Trial watch: DNA vaccines for cancer therapy.	Oncoimmunology	2013	1.11
2	Immunotherapy for brain cancer: recent progress and future promise.	Clin Cancer Res	2014	0.99
3	Emerging human papillomavirus vaccines.	Expert Opin Emerg Drugs	2012	0.96
4	Immunologic treatments for precancerous lesions and uterine cervical cancer.	J Exp Clin Cancer Res	2014	0.96
5	Therapeutic Vaccine Strategies against Human Papillomavirus.	Vaccines (Basel)	2014	0.89
6	Perspectives for therapeutic HPV vaccine development.	J Biomed Sci	2016	0.85
7	Trial watch: Naked and vectored DNA-based anticancer vaccines.	Oncoimmunology	2015	0.83
8	Targeting CD8+ T-cell tolerance for cancer immunotherapy.	Immunotherapy	2014	0.81
9	Cervical Cancer: Development of Targeted Therapies Beyond Molecular Pathogenesis.	Curr Obstet Gynecol Rep	2014	0.79
10	Current state in the development of candidate therapeutic HPV vaccines.	Expert Rev Vaccines	2016	0.79
11	Bacterial vectors for active immunotherapy reach clinical and industrial stages.	Hum Vaccin Immunother	2012	0.78
12	Nonsurgical management of cervical cancer: locally advanced, recurrent, and metastatic disease, survivorship, and beyond.	Am Soc Clin Oncol Educ Book	2015	0.75
13	Immunotherapy: New Strategies for the Treatment of Gynecologic Malignancies.	Oncology (Williston Park)	2016	0.75